Fleshner N E, Fair W R
Urology Service, Memorial Sloan-Kettering Cancer Center, New York, New York, USA.
J Urol. 1997 Feb;157(2):556-8.
We determined the indications for transition zone biopsy in the detection of prostatic carcinoma.
A total of 185 men underwent 204 transition zone prostate biopsies due to elevated prostate specific antigen (PSA) alone in 19 (group 1), with hypoechoic transition zone lesions in 10 (group 2) and with a previous negative transrectal ultrasound guided biopsy in 156 (group 3). In addition, 13 men underwent 19 repeat transition zone biopsies.
Of the patients 58 (31.4%) had positive biopsies, with 8 (4.3%) having cancer in the transition zone biopsies only. In 3 men with positive peripheral and transition zone biopsies the cancer was upgraded based on the transition zone specimens. No patient with elevated PSA and no previous biopsy (group 1) or sonographic transition zone abnormalities (group 2) had a positive transition zone biopsy only. None of the analyzed risk factors (age, PSA, prostate volume, PSA density or PSA velocity) was significantly greater in men with isolated transition zone tumors.
Routine transition zone biopsies should be reserved for patients with previously negative transrectal ultrasound guided biopsies. In some patients disease upgrading based on transition zone biopsies may influence treatment decisions.
我们确定了前列腺移行区活检在前列腺癌检测中的指征。
共有185名男性接受了204次前列腺移行区活检,其中19名(第1组)仅因前列腺特异性抗原(PSA)升高接受活检,10名(第2组)因移行区低回声病变接受活检,156名(第3组)因之前经直肠超声引导下活检结果为阴性而接受活检。此外,13名男性接受了19次重复的前列腺移行区活检。
58名(31.4%)患者活检结果为阳性,其中仅8名(4.3%)在移行区活检中发现癌症。在3名外周区和移行区活检均为阳性的男性中,根据移行区标本对癌症进行了升级。在PSA升高且之前未进行活检的患者(第1组)或超声检查发现移行区异常的患者(第2组)中,没有患者仅移行区活检结果为阳性。在孤立性移行区肿瘤患者中,分析的危险因素(年龄、PSA、前列腺体积、PSA密度或PSA速度)均无显著升高。
常规的前列腺移行区活检应仅用于之前经直肠超声引导下活检结果为阴性的患者。在一些患者中,基于移行区活检的疾病升级可能会影响治疗决策。